Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

Using the right study materials can help strengthen the skills required to crack technical interviews in 2026. They aid in ...

Art Central, the contemporary art fair in Hong Kong which returns for its eleventh edition at the iconic Central Harbourfront from 25–29 March 2026 (VIP Preview on 24 March). Courtesy of Art Central ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

A man used ChatGPT to cure his dog. Here are the stocks for the new age of programmable medicine. Pet owner Paul Conyngham (second right) and Professor Pall Thordarson discussed the cancer vaccine ...

Both Bank of America and JPMorgan are hosting conferences on the industrial sector, featuring presentations from companies including Boeing (BA) and American Airlines (AAL). Delta Air Lines (DAL) ...

Elon Musk’s xAI has brought on board Indian-origin developer Aman Gottumukkala, the founder of Firebender, as part of its ...